Are you Dr. Miller?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 N Campbell Ave
Tucson, AZ 85724Phone+1 520-626-2816Fax+1 520-626-3754
Summary
- Dr. Thomas Miller, MD is an oncologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with Banner - University Medical Center Tucson and is a Professor of Medicine at University Ariz College of Medicine.
Education & Training
- University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1977 - 1980
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1975 - 1977
- University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1972 - 1973
- University of Illinois College of MedicineClass of 1972
Certifications & Licensure
- AZ State Medical License 1980 - 2016
Clinical Trials
- S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma Start of enrollment: 2000 Apr 01
- S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma Start of enrollment: 2004 Feb 01
- Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL Start of enrollment: 2006 May 15
- Join now to see all
Publications & Presentations
PubMed
- 1302 citationsStromal gene signatures in large-B-cell lymphomasGeorg Lenz, George E. Wright, Sandeep S. Dave, Wenming Xiao, Jonathan D. Powell
The New England Journal of Medicine. 2008-11-27 - 759 citationsMolecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin LymphomaAndreas Rosenwald, George E. Wright, Karen Leroy, Xin-You Yu, Philippe Gaulard
The Journal of Experimental Medicine. 2003-09-15 - 1029 citationsPrediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cellsSandeep S. Dave, George E. Wright, Bruce K. Tan, Andreas Rosenwald, Randy D. Gascoyne
The New England Journal of Medicine. 2004-11-18
Professional Memberships
- Member